DG Comp opens pharma probe
Monday, 24 October 2011
Rosalind Donald
The European Commission has announced it is investigating Johnson & Johnson and Novartis over an agreement that could prevent generic versions of the painkiller Fentanyl from entering the market.
Subscription required to view this article
This content can only be accessed by GCR subscribers.
A subscription includes 10 issues of the journal, 2 signature surveys - The GCR100 and Rating Enforcement, 10 GCR special reports and full access to current print and online content.
Please note: If you would like online access to all archived content, you will need a Premium subscription.
If you are a GCR subscriber, please login to access this content:
Comments
You must Subscribe or Log In to make comments.
Comment Terms & Conditions
Back to top